논문KCI 등재
Letter to the editor on “Current burden of steatotic liv er disease and fibrosis among adults in the United States, 2017–2023”
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
관련 논문AI추천
Reply to correspondence on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”Jeayeon Park, Su Jong Yu대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호The burden of steatotic liver disease before and during the COVID-19 pandemic: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”Aijaz Ahmed, Donghee Kim, George Cholankeril, Karn Wijarnpreecha, Pojsakorn Danpanichkul, Rohit Loomba대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Addressing the burden of steatotic liver disease: The role of transient elastography: Correspondence to editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”Aijaz Ahmed, Donghee Kim, George Cholankeril, Karn Wijarnpreecha, Pojsakorn Danpanichkul, Rohit Loomba대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Vibration-controlled transient elastography in shaping the epidemiology and management of steatotic liver disease: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”Daniel Q Huang, Mark Dhinesh Muthiah, Mazen Noureddin, Ming-Hua Zheng, Terry Cheuk-Fung Yip, Xiao-Dong Zhou대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Revealing the importance of a multidisciplinary approach to reducing the global burden of SLD through the COVID-19 pandemic: Editorial on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017–2023”Jeayeon Park, Su Jong Yu대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Prevalence of steatotic liver disease and associated fibrosis in the general population: An epidemiological survey: Letter to the editor on “Epidemiology of metabolic dysfunction-associated steatotic liver disease”Lin Guan, Shanghao Liu, Xiaolong Qi, Xinhe Zhang, Yiling Li대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호
이 간행물의 다른 논문 (76건)
2025 KASL clinical practice guidelines for management of hepatitis CEun Sun Jang, Eun Ju Cho, Chang Hun Lee, Do Seon Song, Nae-Yun Heo, Jae Yoon Jeong, Jung Gil Park, Jae Seung Lee, Jae Hyun Yoon, Seul Ki Han, Young Kul Jungpp. 1-52Critical considerations in evaluating the therapeutic potential of HK-660S for primary sclerosing cholangi tis: Letter to the editor on “Safety and efficacy of HK 660S in patients with primary sclerosing cholangitis: a randomized double-blind phase 2a trial”Yizi He, Haifeng He, Qi Liang, Yongzhi Xiepp. 1-3Letter to the editor on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcino ma: a nationwide cohort study”Xiaodi Yang, Zhongqing Qian, Qiong Wang, Fuliang Chen, Xiaojing Wang, Deyan Chenpp. 7-9Letter to the editor on “GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma”Juan Yang, Xinyi Li, Sheng Zhengpp. 10-12Letter to the editor on “Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target”Ruiyun Guo, Yuqian Liu, Jun Mapp. 13-15